Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.60 |
| ▸ | CNR1 | P21554 | 13/20 | 0.60 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21137737 | 0.89 | CNR2 (0.62) | CNR2CNR1GLRA1 | |
| SCHEMBL15516714 | 0.86 | CNR2 (0.55) | CNR2CNR1GLRA1 | |
| SCHEMBL15506419 | 0.86 | CNR2 (0.55) | CNR2CNR1GLRA1 | |
| SCHEMBL17686855 | 0.81 | DRD3 (0.53) | CNR2CNR1 | |
| SCHEMBL10482595 | 0.80 | CNR2 (0.57) | CNR2CNR1GLRA1 | |
| SCHEMBL10482733 | 0.80 | CNR2 (0.60) | CNR2CNR1 | |
| SCHEMBL17694493 | 0.77 | CNR2 (0.60) | CNR2CNR1GLRA1 | |
| SCHEMBL31545709 | 0.77 | CNR2 (0.60) | CNR2CNR1GLRA1 | |
| SCHEMBL15506421 | 0.77 | CNR2 (0.48) | CNR2CNR1GLRA1 | |
| SCHEMBL17694494 | 0.76 | CNR2 (0.55) | CNR2CNR1GLRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10882838-B2 | Cannabinergic compounds and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190185443-A1 | Novel Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190185443-A1 | Novel Cannabinergic Compounds And Uses Thereof | CNR2, CNR1, GPR18 | CNR2 1/4885CNR1 2/4885GLRA1 565/4885 |
| US-10882838-B2 | Cannabinergic compounds and uses thereof | CNR2, CNR1, GPR18 | CNR2 1/4885CNR1 2/4885GLRA1 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.